PC 815
Alternative Names: MIV-150/PC-515; PC-815Latest Information Update: 04 Nov 2017
At a glance
- Originator Medivir AB
- Developer Population Council (USA)
- Class Antivirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in HIV-infections(Prevention) in Dominican Republic (Vaginal)
- 04 Nov 2017 No recent reports of development identified for phase-I development in HIV-infections(Prevention) in South Africa (Vaginal)
- 05 Jun 2007 PC 815 is still in active development